Signaturefd, LLC Novo Cure LTD Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Signaturefd, LLC holds 1,279 shares of NVCR stock, worth $21,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,279

Previous 1,644 22.2%

Holding current value

$21,858

Previous $28,000 32.14%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$15.61 - $23.34 $5,697 - $8,519	-365 Reduced 22.2%	1,279 $19,000
Q2 2024 Jul 29, 2024	BUY	$11.83 - $24.05 $7,417 - $15,079	627 Added 61.65%	1,644 $28,000
Q1 2024 May 03, 2024	BUY	$12.42 - $17.29 $2,496 - $3,475	201 Added 24.63%	1,017 $15,000
Q4 2023 Jan 31, 2024	BUY	$11.13 - $15.78 $1,179 - $1,672	106 Added 14.93%	816 $12,000
Q3 2023 Nov 03, 2023	BUY	$16.15 - $42.35 $2,939 - $7,707	182 Added 34.47%	710 $11,000
Q2 2023 Aug 01, 2023	SELL	$40.29 - $82.51 $14,182 - $29,043	-352 Reduced 40.0%	528 $21,000
Q1 2023 Apr 28, 2023	SELL	$56.44 - $118.81 $5,192 - $10,930	-92 Reduced 9.47%	880 $52,000
Q4 2022 Jan 27, 2023	SELL	$63.98 - $85.37 $4,862 - $6,488	-76 Reduced 7.25%	972 $71,000
Q3 2022 Nov 08, 2022	SELL	$67.99 - $89.57 $34,470 - $45,411	-507 Reduced 32.6%	1,048 $80,000
Q2 2022 Aug 10, 2022	BUY	$56.6 - $89.9 $10,188 - $16,182	180 Added 13.09%	1,555 $108,000
Q1 2022 May 02, 2022	BUY	$60.15 - $84.52 $51,247 - $72,011	852 Added 162.91%	1,375 $114,000
Q4 2021 Jan 25, 2022	BUY	$75.08 - $121.99 $14,790 - $24,032	197 Added 60.43%	523 $39,000
Q3 2021 Oct 28, 2021	SELL	$116.17 - $194.55 $13,824 - $23,151	-119 Reduced 26.74%	326 $38,000
Q2 2021 Jul 26, 2021	BUY	$130.4 - $225.58 $7,824 - $13,534	60 Added 15.58%	445 $99,000
Q1 2021 Apr 30, 2021	BUY	$124.11 - $190.17 $5,584 - $8,557	45 Added 13.24%	385 $51,000
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $5,495 - $8,532	49 Added 16.84%	340 $59,000
Q3 2020 Nov 03, 2020	BUY	$58.05 - $111.31 $10,158 - $19,479	175 Added 150.86%	291 $32,000
Q1 2020 Apr 23, 2020	BUY	$57.05 - $95.75 $5,762 - $9,670	101 Added 673.33%	116 $8,000
Q4 2019 Feb 05, 2020	BUY	$68.3 - $93.8 $1,024 - $1,407	15 New	15 $1,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.79B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account